Illinois Governor ‘Tremendously Disappointed’ By Failure Of Hemp Product Restriction Bill Amid Democratic Infighting
Colorado Regulators Can Now Issue Psychedelic-Assisted Therapy Licenses Ahead Of Program’s Launch Later This Year
Ukraine Officials Give Final Approval To Country’s First Medical Cannabis Products Under New Legalization Law
DEA Judge Orders Agency To Respond To New Allegations It Opposes Marijuana Rescheduling And Improperly Conspired With Prohibitionists
New York Marijuana Consumption Lounges Could Sell Food And Drinks While Hosting Live Concerts Under New Bill
Legalizing Medical Marijuana Leads To ‘Significant Decrease’ In Opioid Companies’ Payments To Pain Doctors, Study Shows
Scientists Explore How Marijuana Affects Enjoyment Of Music Through New Study At Cannabis Lounge
Young Adults Are Three Times More Likely To Use Marijuana On A Near-Daily Basis Than Alcohol, Federally Funded Study Finds
Cannabis Pollen Travels Far And Wide On The Wind, Study Shows, Raising Concerns For Cross-Pollination Of Hemp Crops
Oregon’s Psilocybin Industry Aims To Fine-Tune State’s First-In-Nation Therapeutic Psychedelics System In 2025
Sports Leagues Took Steps To Update Their Marijuana Policies As The Legalization Movement Grew In 2024
This Company Wants To Pay You To Smoke Marijuana And Write ‘Amazing Reviews’
NFL Adopts New Marijuana Policy For Players, Reducing Fines And Increasing THC Limit For Drug Tests
Basketball Star Brittney Griner Will Speak At Cannabis Leadership Conference, Group Announces
Snoop Dogg Launches Online Cannabis Store Selling Hemp-Derived THCA Products And Smoking Supplies
CBD Tampon Maker Pulls Products Off U.S. Market Following FDA Warning Letter
Ohio Businesses Sold $242 Million Worth Of Recreational Marijuana In 2024, State Agency Says
New York Retailers Have Now Officially Sold $1 Billion Worth Of Legal Marijuana, Governor Announces
Analysts See ‘Sudden Spike’ In Use Of Marijuana As An Alcohol Alternative
New Jersey Marijuana Sales Top $1 Billion Mark For 2024, State Officials Announce
Illinois Governor ‘Tremendously Disappointed’ By Failure Of Hemp Product Restriction Bill Amid Democratic Infighting
Kentucky Governor Shares Tips On How To Register For Medical Marijuana Access
Biden Dodges Question About Releasing Marijuana Prisoners Before Leaving Office, As He Previously Promised He Would Do
Former Texas Governor Who Served In Trump’s Cabinet Says President-Elect’s Health Picks Are A ‘Great Gift’ For Psychedelics Reform
Maryland’s Biggest County Seeks To Loosen Marijuana Use Restrictions For Police Recruits Amid Staffing Shortage
DEA opposes cannabis rescheduling, new legal filing says (Newsletter: January 8, 2025)
Wisconsin governor wants to put cannabis on the ballot (Newsletter: January 7, 2025)
NY could see $1.5 billion in cannabis sales in 2025 (Newsletter: January 6, 2025)
New congressional cannabis leaders take up push for reform in 2025 (Newsletter: January 3, 2025)
NY hits $1 billion in legal cannabis sales (Newsletter: January 2, 2025)
Published
on
By
A new scientific review says cannabis oil may help promote the healing of skin wounds, finding that it offers “promising benefits” despite a need to better optimize product formulations.
The report, by researchers at universities in India and Thailand, looked specifically at how cannabis oil can reduce so-called “reactive oxygen species” (ROS) during the healing of wounds. Those chemicals “play a crucial role in would development by causing cell and tissue damage,” it explains.
“Increased ROS levels can hinder wound healing by exacerbating inflammation and cellular damage,” the paper, published in the journal Pharmaceutics says. “CBD’s antioxidant properties mitigate these effects, fostering a more conducive environment for tissue regeneration.”
Specifically, authors wrote that the cannabis oil “may help mitigate oxidative damage by scavenging ROS and upregulating antioxidative mechanisms, potentially enhancing wound healing.”
“CBD’s therapeutic effects in wound healing are largely attributed to its antioxidant, anti-inflammatory, and antimicrobial properties.”
“Cannabis oil, especially its primary bioactive constituents, CBD and THC, demonstrates considerable potential in facilitating skin wound healing by modifying oxidative stress via the regulation of reactive oxygen species,” the research says, adding that the antioxidant properties of CBD mitigate the effects of ROS, “fostering a more conducive environment for tissue regeneration.”
“Additionally, the antibacterial and analgesic properties of cannabis contribute to reducing the microbial load and minimizing the complications associated with chronic wounds,” authors added, “thereby enhancing the overall healing efficacy.”
The review looked at previously published literature on cannabis and wound healing, noting that the research so far has been rather thin.
“Despite extensive research into the pharmacological and pharmacokinetic properties of CBD, there are surprisingly few clinical trials focused specifically on its application in wound healing,” it says. “However, these studies lay a strong foundation for understanding how CBD behaves in the body, its safety profile, and its potential therapeutic effects across various conditions.”
In part because of the limited research into cannabis oil for wound treatment so far, authors call for further inquiry into how cannabis oil functions in wound treatment and how product might be better formulated to optimize healing.
“Integrating cannabis oil into drug delivery systems for wound management represents a promising strategy for treating both acute and chronic wounds.”
“Despite its promising benefits,” authors wrote, “optimizing cannabis oil formulations for therapeutic applications remains a challenge, underscoring the need for further research to realize its medicinal capabilities in wounds.
The research comes as more studies explore the use of cannabis to treat pain and injuries.
In terms of therapeutic use, marijuana as a pain reliever is widely reported as the most common reason that people use the drug. A recent study of consumers found that pain management was the most popular motivation for cannabis use, and chronic pain is the most frequently listed qualifying condition in many state medical marijuana programs.
A study published this summer, meanwhile, found that cannabis was more effective at treating musculoskeletal pain than traditional medications are, with more than 90 percent of patients calling medical marijuana at least slightly effective.
“More than half (57%) claimed cannabis to be more effective than other analgesic medications, and 40% reported decreasing their use of other analgesic medications since starting cannabis use,” said that paper, published in the Journal of Cannabis Research, adding that only 26 percent reported a doctor recommended cannabinoids to them to treat their musculoskeletal (MSK) pain.
In April, a federal research meeting brought together representatives of various U.S. agencies to discuss the use of cannabis components to treat pain, with a special focus on minor cannabinoids and marijuana terpenes.
A federally funded study published in May indicated that terpenes could be “potential therapeutics for chronic neuropathic pain,” finding that an injected dose of the compounds produced a “roughly equal” reduction in pain markers when compared to a smaller dose of morphine. Terpenes also appeared to enhance the efficacy of morphine when given in combination.
Unlike with morphine, however, none of the studied terpenes produced a meaningful reward response, the research found, indicating that “terpenes could be effective analgesics with no rewarding or dysphoric side effects.”
Another recent study, published in the Journal of the American Medical Association, found that most marijuana consumers use the drug to treat health issues at least sometimes, but very few consider themselves medical marijuana users.
“Less than half the patients who used cannabis reported using it for medical reasons, even though the majority of patients reported cannabis use to manage a health-related symptom,” authors of that study wrote. “Given these discrepant findings, it may be more useful for clinicians to ask patients what symptoms they are using cannabis for rather than relying on patient self-identification as a recreational or medical cannabis user.”
“This aligns with another study that found that this type of cannabis use is clinically underrecognized,” they added, “and without specifically screening for medical cannabis use, clinicians may not ask and patients often do not disclose their use.”
Marijuana Components Show ‘Promising Potential As Anticancer Agents,’ Study Finds, Though Mechanisms Of Action Are Still A Mystery
Photo courtesy of Kimzy Nanney.
Is Hemp-Derived CBD A Good Treatment For Marijuana Use Disorder? Researchers Aim To Find Out With New Study Plan
Most People Don’t Trust The Government For Marijuana Information, Federally Funded Study Shows
Ben Adlin, a senior editor at Marijuana Moment, has been covering cannabis and other drug policy issues professionally since 2011. He was previously a senior news editor at Leafly, an associate editor at the Los Angeles Daily Journal and a Coro Fellow in Public Affairs. He lives in Washington State.
CBD Tampon Maker Pulls Products Off U.S. Market Following FDA Warning Letter
Illinois Governor ‘Tremendously Disappointed’ By Failure Of Hemp Product Restriction Bill Amid Democratic Infighting
Colorado Regulators Can Now Issue Psychedelic-Assisted Therapy Licenses Ahead Of Program’s Launch Later This Year
Ukraine Officials Give Final Approval To Country’s First Medical Cannabis Products Under New Legalization Law
DEA Judge Orders Agency To Respond To New Allegations It Opposes Marijuana Rescheduling And Improperly Conspired With Prohibitionists
New York Marijuana Consumption Lounges Could Sell Food And Drinks While Hosting Live Concerts Under New Bill
All the cannabis news you need, all in one place. Copyright © 2017-2025 Marijuana Moment LLC ® and Tom Angell